Advanced in Prostate Cancer

Volker Budach

Berlin, BE, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Prostate Cancer
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Volker Budach practices in Berlin, Germany. Mr. Budach is rated as an Advanced expert by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Meningioma, Human Papillomavirus Infection, Prostatectomy, and Mastectomy.

His clinical research consists of co-authoring 219 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 28 articles in the study of Prostate Cancer.

Gender
Male

Locations

Berlin, BE 13353, Germany
Other Locations
Heidelberg, BW, Germany
Dresden, SN, Germany
Munich, BY, Germany
Koeln, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head and Neck Squamous Cell Carcinomas: A Phase I Study to Reduce Late Toxicity
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head and Neck Squamous Cell Carcinomas: A Phase I Study to Reduce Late Toxicity
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
An Open Label, Phase Ia/Ib Trial of the DNA-PK Inhibitor MSC2490484A in Combination With Radiotherapy in Patients With Advanced Solid Tumors
An Open Label, Phase Ia/Ib Trial of the DNA-PK Inhibitor MSC2490484A in Combination With Radiotherapy in Patients With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1
Observational Study on Biomarkers in Head and Neck Cancer
Observational Study on Biomarkers in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: August 03, 2022
Intervention Type: Biological
View 2 Less Clinical Trial

219 Total Publications

Integrating MALDI-MSI-Based Spatial Proteomics and Machine Learning to Predict Chemoradiotherapy Outcomes in Head and Neck Cancer.
Integrating MALDI-MSI-Based Spatial Proteomics and Machine Learning to Predict Chemoradiotherapy Outcomes in Head and Neck Cancer.
Journal: International journal of molecular sciences
Published: July 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Budach's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile